Biovie (BIVI) Payables (2013 - 2026)
Biovie (BIVI) posted Payables of $1.6 million for Q1 2026, down 44.88% sequentially from $2.9 million in Q4 2025, and down 34.92% YoY from $2.5 million in Q1 2025.
Biovie (BIVI) Payables (2013 - 2026) Analysis & Trends
Biovie has reported Payables for 14 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Payables fell 34.92% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 34.92% YoY) and the FY2025 annual result came in at $2.2 million, down 76.31% from the prior year.
- Payables fell to $1.6 million in Q1 2026 per BIVI's latest filing, from $2.9 million in the prior quarter.
- Over five years, Payables peaked at $13.8 million in Q4 2023 and troughed at $1.2 million in Q1 2022.
- A 5-year average of $5.9 million and a median of $2.9 million in 2025 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2024: Payables jumped 830.95% in 2023, then slumped 89.98% in 2024.
- Over 5 years, Payables stood at $3.2 million in 2022, then surged by 325.32% to $13.8 million in 2023, then plunged by 89.98% to $1.4 million in 2024, then surged by 111.45% to $2.9 million in 2025, then slumped by 44.88% to $1.6 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $1.6 million, $2.9 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Biovie | 13.77 Mn | 13.77 Mn | - | 3.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.70 Mn |
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 6.77 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Dec 31, 2023 | 13.80 Mn |
| Sep 30, 2023 | 12.05 Mn |
| Jun 30, 2023 | 12.58 Mn |
| Mar 31, 2023 | 11.23 Mn |
| Dec 31, 2022 | 3.25 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 679,393.00 |